- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Boryung Pharm (003850)
Boryung Pharm stock price live, this page displays KS 003850 stock exchange data. View the 003850 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Boryung Pharm real time stock price chart below.
What Is the Boryung Pharm Stock Price Today?
The Boryung Pharm stock price today is 9,280.
What Is the Stock Symbol for Boryung Pharm?
The stock symbol for Boryung Pharm is "003850."
What Stock Exchange Does Boryung Pharm Trade On?
Boryung Pharm is listed and trades on the Seoul stock exchange.
Is Boryung Pharm a Good Stock to Buy?
Determining whether Boryung Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003850 quote. (ISIN: KR7003850005)
What Is the Boryung Pharm Stock Price Today?
The Boryung Pharm stock price today is 9,280.
What Is the Stock Symbol for Boryung Pharm?
The stock symbol for Boryung Pharm is "003850."
What Stock Exchange Does Boryung Pharm Trade On?
Boryung Pharm is listed and trades on the Seoul stock exchange.
Is Boryung Pharm a Good Stock to Buy?
Determining whether Boryung Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003850 quote. (ISIN: KR7003850005)
Seoul
Currency in KRW
9,280
+120(+1.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,980
9,360
52 wk Range
7,680
10,520
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,9809,360
52 wk Range
7,68010,520
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.08%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.08%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003850 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
13,000
Upside
+40.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Boryung Pharm Company Profile
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Compare 003850 to Peers and Sector
Metrics to compare | 003850 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003850PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.9x | 12.6x | −0.6x | |
PEG Ratio | −0.52 | −0.28 | 0.00 | |
Price/Book | 1.0x | 1.0x | 2.6x | |
Price / LTM Sales | 0.8x | 0.7x | 3.4x | |
Upside (Analyst Target) | 40.1% | 29.9% | 43.4% | |
Fair Value Upside | Unlock | 13.0% | 6.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13,000
(+40.09% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
404.92 / --
Revenue / Forecast
280.01B / 280.40B
People Also Watch
FAQ
What Is the Boryung Pharm (003850) Stock Price Today?
The Boryung Pharm stock price today is 9,280
What Stock Exchange Does Boryung Pharm Trade On?
Boryung Pharm is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for Boryung Pharm?
The stock symbol for Boryung Pharm is "003850."
Does Boryung Pharm Pay Dividends? What’s The Current Dividend Yield?
The Boryung Pharm dividend yield is 1.08%.
What Is the Boryung Pharm Market Cap?
As of today, Boryung Pharm market cap is 783.98B.
What Is Boryung Pharm's Earnings Per Share (TTM)?
The Boryung Pharm EPS (TTM) is 688.80.
When Is the Next Boryung Pharm Earnings Date?
Boryung Pharm will release its next earnings report on Feb 08, 2026.
From a Technical Analysis Perspective, Is 003850 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Boryung Pharm Stock Split?
Boryung Pharm has split 19 times.
How Many Employees Does Boryung Pharm Have?
Boryung Pharm has 1533 employees.
What is the current trading status of Boryung Pharm (003850)?
As of Jan 29, 2026, Boryung Pharm (003850) is trading at a price of 9,280, with a previous close of 9,280. The stock has fluctuated within a day range of 8,980 to 9,360, while its 52-week range spans from 7,680 to 10,520.
What Is Boryung Pharm (003850) Price Target According to Analysts?
The average 12-month price target for Boryung Pharm is KRW13,000, with a high estimate of KRW13000 and a low estimate of KRW13000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +40.09% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.